Project to focus on drug development for schizophrenia, depression

01/19/2010 | EurekAlert!

An international team of researchers, headed by H. Lundbeck A/S and King's College London, has formed the Novel Methods leading to New Medications in Depression and Schizophrenia, an academic-industry research tie-up that will focus on finding new ways to develop treatments for schizophrenia and depression. The project aims to develop new animal models for brain studies, as well as hardware and analysis methods that can be used in brain imaging, including MRI and PET.

View Full Article in:

EurekAlert!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT